2022 Global Drug Bioavailability Enhancement Summit

“The 2022 Global Drug Bioavailability Enhancement Summit will connect industry leaders from both small molecule and biologics areas to address challenges at the interface between drug discovery and preclinical/clinical development. 2022’s Summit will share cutting edge research on the development, characterization and manufacture of formulations that span multiple modalities. Hear from 30+ senior drug bioavailability pioneers and network with 120+ senior drug development innovators”.